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Abstract
Periodontal diseases are ubiquitous diseases. They can affect people through a chronic
infection that happens over a lifetime, but also as an aggressive infection that afflicts the younger
population. It not only results in tooth loss and a lower quality of life, but it can also lead to fatal
secondary infections like cervical cancer, heart disease, and Alzheimer’s disease. This study
looks at Selenomonas sputigena, an emerging oral pathogen, that has been hypothesized to
contribute to periodontal disease. It has been linked to fatal septicemia and has been found in
increased abundance within the oral biofilm during peak infection. Though S. sputigena had been
discovered decades ago, there is little to no knowledge about its growth factors, both in vivo and
in vitro, let alone virulence factors and disease-causing ability. In addition to establishing basic
growth conditions for this understudied organism, understanding potential virulence factors for
Selenomonas sputigena as an oral pathogen was the focus of this study. These potential factors
for this organism include the ability to sense and make swift changes to the oral environment
when it comes to pH, temperature, and oxygen concentration, sense and respond to other oral
bacteria along with formation of biofilms, cell wall and potassium homeostasis, adhesion,
motility, and flagellar assembly. Some of these virulence factors are proposed to be dependent
upon the understudied cyclic dinucleotide, cyclic-di-AMP. Cyclic-di-AMP is the proposed
secondary messenger that S. sputigena utilizes. A diadenylate cyclase, SELSP_1610, a
phosphodiesterase, SELSP_2051, and two TetR family transcriptional regulators, SELSP_1770
and SELSP_1836, were all proposed based off of sequence comparison to other pathogenic oral
bacteria, with special emphasis placed on SELSP_1610.
Throughout this study, we established previously unknown growth conditions within the
laboratory for S. sputigena. Growth rates and growth characteristics were studied both in broth
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and on agar plates. The determination of oxygen sensitivity was also noted along with sensitivity
to different antibiotics. Next, the focus turned to the characterization of virulence factors by
studying biofilm development with self, hemagglutination and hemolysis, and binding of S.
sputigena to gingival epithelial cells. After these virulence factors had been assessed, the cloning
process was started and extensive assay development using reverse phase chromatography was
performed. This was used to better characterize cyclic-di-AMP metabolism in S. sputigena
specifically to study the enzyme, SELSP_1610, and its potential activity as a diadenylate cyclase
when converting two molecules of ATP into cyclic-di-AMP. While diguanylate cyclase had been
successfully studied in the past using HPLC, diadenylate cyclase had not been. This new
approach required development of the assay to assess diadenylate cyclase activity by extensively
adjusting the variables and conditions used. Here, we optimized enzyme kinetics, buffer
conditions and concentrations, as well as the activating cations. Further results are needed to
support that SELSP_1610 fits as a diadenylate cyclase. Furthermore, a competitive ELISA using
a known control is also being utilized to further support the hypothesis that SELSP_1610 is a
diadenylate cyclase. This foundational research will be built upon in the future to further
characterize Selenomonas sputigena as a periodontal pathogen.
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Chapter 1: Introduction and background information
Periodontal disease
Periodontal disease is a chronic inflammatory disease that affects the tissue and bone that
support the teeth (5,57,61). It is a progressive disease that affects approximately 47.2% of adults,
as of 2015, within America alone (1,2,76). This disease not only affects people in an economic
aspect all over the world, but it also contributes to a reduced quality of life due to pain, tooth
loss, and trouble with mastication (1,29,68). Periodontal disease has two aspects to it: gingivitis
and periodontitis (57,61). Gingivitis, the reversible stage, is defined as inflammation in the
gingiva due to the progressive buildup of plaque over time (Figure 1-2)(57). This inflammation
can worsen the epithelium and connective tissue around the tooth, eventually leading to its
erosion if proper treatment is not sought (4,57,61). The tooth is unharmed at this stage; however,
if left untreated it can progress to periodontitis (57,61). Unlike gingivitis, periodontitis is more
difficult to treat and results in chronic inflammation and the destruction of periodontal ligaments
(Figure 1-1) (57). Once the support from the tooth has been removed, the gap begins to grow
between the tooth and gums (57). Destruction of teeth and the underlying alveolar bone begins,
and the loss of ligaments results in edentulism, or loss of teeth (57,71). Severe tooth loss, losing
one tooth or more, can come from this progression of disease (57). Periodontitis has two types:
chronic and aggressive (55,57,61).

7

Keller

Figure 1-1 Progression of periodontal disease
Progression of periodontal disease from healthy, to gingivitis, to periodontitis exhibiting
the inflammation of the gingival epithelium and the resection of alveolar support
eventually resulting in destruction of gums and teeth.
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Figure 1-2 Plaque Formation in the Subgingival Sulcus
Progression of periodontal disease from healthy to disease state with respect to the
buildup of plaque, first on the tooth, in the gingival sulcus and then subgingival space as
inflammation increases and gum and bone loss occurs (60,61,70).
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Chronic periodontitis is progressive and spans the lifetime of the afflicted person (57,68).
It comes from poor hygiene and is usually found in the adult demographic later in life (57,61).
The prevalence increases by 70.1% in adults over the age of 65 and usually presents in adults
over the age of 30 (1,2,68,76). Within the United States, half of the nation’s adults over 30 have
chronic periodontal disease (1,2,53,68,76). It appears to be linked to the gradual shift from
synergy of oral microorganisms to dysbiosis (6,7,57). This shift from healthy to disease state is
essential to this process and will be expanded upon later in the introduction (7). Its dependence
on oral microbial dysbiosis allows for preventative measures to be taken to reduce the chances of
development (6,7). There seems to be a reduced genetic link when it comes to this form of
periodontitis in comparison to its counterpart.
However, unlike chronic periodontitis, aggressive periodontitis does have a strong
genetic component to it (57,61). It mainly affects people under the age of 30 and mitigation of
the disease, not prevention, is the only suitable option (57). In addition to the genetic component,
Aggregatibacter actinomycetemcomitans has been implicated in the progression of aggressive
periodontitis due to its ability to allow other oral bacteria to proliferate (7,50,55). This Gramnegative commensal bacterium has a myriad of virulence factors that makes it the leading cause
of this type of periodontal disease (7). If left untreated, it can lead to infections like endocarditis
and bacteremia (57). Though treatment is a necessity after infection has occurred, unfortunately
aggressive periodontitis does not have the ability to be prevented.
Certain factors can increase the risk of developing periodontal disease. As chronic
periodontal disease is developed over time, poor oral hygiene, as previously mentioned, can
contribute to development of this disease (57,68,71). The consumption of high amounts of sugar
and carbohydrates without regular brushing/mechanical abrasion put those with this kind of diet
10
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at high risk (57,68,71). There are other preexisting conditions as well that contribute such as dry
mouth, caused by stress or medications, and diabetes (68,71). Smoking can also increase the risk
(68,71). Lack of access to proper nutrition and oral care, like regular dental cleaning, can also
contribute to this (68,71). This means that people that live below the poverty line are more at risk
than those who have access to proper care (76). This paired with a lack of education creates
problems later in life when chronic periodontitis sets in (76). This can result in often serious
secondary infections (4,71). These infections can occur in parts of the world where dental care is
not easy to come by, including those who cannot afford dental care (29).
Secondary infection is not just localized to the oral cavity. Once the bacteria enter the
blood, bacteremia can and does occur along with the spread of odontogenic infections into the
jaw and face (4,40,42,57). Other long-term sequela of periodontal disease has been linked to
heart disease, stroke, and cancer such as cervical cancer (4,7,11,71). Adverse birth outcomes due
to oral bacteria being found in the placenta and amniotic fluid can lead to premature births
(32,71). Rheumatoid arthritis and Alzheimer’s disease have also been found to stem from
periodontal disease (5,7,43). These detrimental secondary conditions branch directly from
chronic and aggressive periodontitis being a chronic inflammatory disease that results in years of
inflammation (57,61). Treatment of these conditions depends on catching, preventing, and
treating the primary infection early.
Prevention of chronic periodontitis is dependent upon hygiene management (68). Proper
mechanical abrasion, such as brushing and flossing, can reduce risk along with yearly dental
exams to maintain the integrity of the teeth (68). These little changes are key to offsetting the
disease later in life. However, if chronic periodontal disease has already set in, or aggressive
periodontal disease has been discovered, treatment by scaling and planing and debridement, or
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the removal of plaque from the roots of the tooth, is the first step (38,54,68). This particular
method is an attempt to control and prevent further bacterial infection (38,68). Antibiotic
treatment, such as tetracycline and doxycycline, does exist; however, it is limited in its
effectiveness and should be used in tandem with this initial treatment (4,38,54). Depending on
how drastic the damage becomes, cutting away the gums to clean the roots and surgery for tooth
repair and tooth removal may be a necessary treatment plan (4,38,54).
Between chronic and aggressive periodontitis, there are only a limited number of
treatment and prevention options available (38,68). Despite being a ubiquitous disease that
affects a vast portion of the population worldwide, with detailed knowledge about its
progression, treatment options are not what they could be (38,68). Treatment options and
therapies are expensive and invasive and, in addition, can be ineffective (4,38). Current treatment
methods require more attention and development. They only serve to mitigate the damage
already caused, and as stated before, there is no solid prevention for aggressive periodontitis
(38). With the increased risk of a secondary complication occurring from periodontal disease, the
only hope of being able to properly care for those that suffer with this disease is to study the
interactions between the organisms within the oral microbiome and target them for a particular
treatment plan (68).

Oral Microenvironment: Synergy and Dysbiosis
The movement from healthy to disease state within the polymicrobial microenvironment
is a necessary direction to take when studying the oral microbiome (6,7,29). The oral
microbiome is diverse and expansive with over 700 different species of bacteria that reside
within the mouth (7,57,67). The range of temperatures, changes in pH, oxygen content, flow of
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saliva and diversity of surfaces make this a dynamic location for bacteria to grow (57,60).
Commensal bacterial populations out-compete pathogenic bacteria, add to homeostatic
inflammation, and regulate the oral immune response (57,60). This leads to a state of chronic
inflammation that leads to the destruction of supportive tissue, alveolar bone, and eventual tooth
loss (57). This shift from a synergistic state to a state of dysbiosis triggers proliferation of
pathogenic bacteria and initiates the production of proinflammatory cytokines and chemokines
eventually leading to the activation of the host immune response (7,23,30).
Interactions between various bacterial species are complex and finely tuned in order to
signal community adaptation (Figure 1-3) (6,48,67). Other pathogenic bacteria rely on these
keystone pathogens to colonize specific niches within the oral cavity and helps to decrease the
commensal bacteria (6,24,26). This turning point is key in the propagation of periodontal disease
(67). Particular pathogenic bacteria such as Treponema denticola, Porphyromonas gingivalis,
and Aggregatibacter actinomycetemcomitans have all been studied extensively and are known to
make this shift occur (7,46,50,55). In addition to these classically recognized pathogens, oral
microbiome studies have discovered several underappreciated pathogens like Filifactor alocis
(5,6). An emerging pathogen that has been recently highlighted is Selenomonas sputigena (77).
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Figure 1-3 A diagram of plaque formation
This diagram of plaque formation illustrates the ability of most oral bacteria to effectively
communicate and form organized aggregations. This is to either maintain synergistic interactions
or facilitate dysbiosis and lead to a state of disease (6,45,51,70).
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Selenomonas sputigena
S. sputigena is a Gram-negative, vibrio shaped motile bacteria with multiple flagella
located in the inner crescent (47,77). The prevalence and abundance of Selenomonas sputigena
increases from a healthy state to periodontitis (77). It was discovered in the early 1950’s to be
involved in the process of periodontal disease formation (41,56,77,78). Inflammation of the
gingiva has also been shown to occur during its proliferation. It has also been implicated in fatal
septicemia, a secondary infection, and is now being used as an indicator of disease as it was
discovered throughout the oral biofilm (56,77). Through modern 16S sequencing that takes
samples from both healthy and disease state, and metatranscriptomics, more pathogenic bacteria
have been identified than previously known before (6,14,37). As mentioned above, Filifactor
alocis is a newly discovered, and now verified, oral pathogen (5,6). Selenomonas sputigena has
not been looked at as of late and is only now just being studied. It and other members of
Selenomonas such as Selenomonas flueggei and Selenomonas noxia have been shown to interact
with other oral pathogenic bacteria such as Fusobacterium nucleatum (21,31,78). The
selenomonads do not form coaggregations with themselves; however, they do with F. nucleatum
(21,31,78). Sequencing has also pointed to it having potential pathogenic virulence qualities that
match other oral pathogens. Though evidence has been pointing to this possibility, it is unknown
if it directly promotes periodontal disease and not many specifics are known about this
bacterium. Defining these aspects, along with the growth conditions, is an essential part of this
study as S. sputigena is a relatively understudied organism and its pathogenic capabilities and
virulence factors are undiscovered (6,7,77). Due to its presence in the oral cavity, swift
adaptation to the oral microenvironment is a necessity when it comes to oxygen concentration,
pH, and temperature. It also may have the ability to sense and respond to other oral bacteria
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along with biofilm formation. Cell wall and potassium homeostasis, adhesion to gingival
epithelial cells, motility, and flagellar assembly are also proposed capabilities of S. sputigena
(16,28,39,56). S. sputigena also has lipopolysaccharide that mirror other Gram-negative bacteria
(79). Some of these responses and virulence factors are proposed to be dependent upon the
understudied cyclic dinucleotide, cyclic-di-AMP: the secondary messenger that S. sputigena
uses.
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Figure 1-4 Selenomonas sputigena schematic
This figure exhibits the vibrio, or crescent shape, of S. sputigena complete with the
presence of flagella coming from the inner curve.
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Cyclic-di-GMP
Cyclic-di-GMP or cyclic dimeric guanosine 3’,5’-monophosphate (Figure 1-5), which
was originally discovered in the 1980’s to regulate cellulose synthesis, in comparison to cyclicdi-AMP, is the most well-known and well-studied secondary messenger (62). Cyclic-di-GMP
regulates multiple functions including cell signaling, biofilm development, and other intracellular
functions including the regulation of virulence factors (28,62). Cyclic dinucleotides, such as
cyclic-di-GMP, which control production of exopolysaccharides, are essential when it comes to
bacteria not only responding to environmental stressors, but also when responding to each other
(62). Cyclic-di-GMP, for example, helps to not only promote motility but also controls biofilm
formation and maturation through regulation of fimbriae production and adhesins (28,62). This
ubiquitous secondary messenger has been studied extensively in bacteria for a full 30 years. Its
activities are modulated through phosphodiesterases for degradation and diguanylate cyclases for
synthesis. Cyclic-di-GMP synthesis relies on two molecules of GTP and a diguanylate cyclase,
which have a GGEEF/GGDEF domain, converts the GTP into cyclic-di-GMP with Mg2+ as the
activating cation (62). When c-di-GMP is degraded by a phosphodiesterase, the two left over
molecules are GMP and pGpG, which eventually converts into GMP (62,64). The domain EAL
needs Mn2+ or Mg2 and results in the degradation of c-di-GMP and produces the nucleotide
pGpG (62,64). HD-GYP, a third domain, is a part of the HD superfamily, or the metal-dependent
phosphohydrolases (62,64). HD-GYP also acts as a c-di-GMP phosphodiesterase in addition to
EAL (62,64). Along with this function, HD-GYP has also been proposed to regulate pGpG
(62,64). After its synthesis, C-di-GMP interacts with effector RNA (riboswitches) or effector
proteins, including PilZ domain that helps to regulate motility in Treponema denticola (9,36,75).
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As previously stated, cyclic-di-GMP has been extensively studied; however, cyclic-di-AMP,
another secondary messenger, is understudied in comparison.
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Figure 1-5 cyclic dimeric guanosine 3’,5’-monophosphate
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Cyclic-di-AMP
Cyclic-di-AMP has been found to be an essential secondary messenger like cyclic-diGMP (8,10,16,17,18). It was only discovered as early as 2008 in bacteria and, in comparison to
cyclic-di-GMP, it is inadequately understood (17,20,76). It, like its counterpart, is responsible for
responding and adapting to the environment and other surrounding bacteria, regulates motility,
and has been shown in biofilm development (17,74,76). It also facilitates potassium and cell wall
homeostasis, chemotaxis, and regulates virulence factors (17,39,76). It is mostly found in Grampositive bacteria and it is less common for Gram-negative bacteria to have this trait. It is found in
Gram-negative phyla such as Chloroflexi, Spirochetes, Acidobacteria, and from the phylum
Firmicutes (33). S. sputigena, though Gram-negative, is a member of Firmicutes and is
hypothesized to use cyclic-di-AMP as a secondary messenger (17,58). S. sputigena comes from
the phylum firmicutes, a typically Gram-positive phylum, therefore this secondary messenger
might be highly conserved (17,58). Cyclic-di-AMP within S. sputigena has a myriad of uses as it
not only regulates potential virulence factors but also aids the bacterium in adapting to
environmental conditions and abrupt changes found within the mouth (3).
Cyclic-di-AMP can be synthesized from two molecules of ATP by several different types
of diadenylate cyclases, or DAC, like DacA in S. aureus and DacB in B. subtlis (Figure 1-7)
(17,20,22,25,33). Within S. sputigena, the gene coding for this particular diadenylate cyclase,
and the focus of this thesis, is hypothesized to be SELSP_1610 (Figure 1-6). In terms of potential
receptors for cyclic-di-AMP, in comparison to cyclic-di-GMP, which has multiple different
binding molecules identified, very little have been discovered yet (25,33). Though it does not
have a PilZ equivalency, cyclic-di-AMP has its own set of receptor types such as transcriptional
regulators, enzymes, and transporters that bind to it (25,33,73). These regulator proteins bind to
21
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cyclic-di-AMP and allosterically change when bound to in order to specifically regulate
pathways (17,25,33,66). For example, to help regulate osmotic pressure through K+ transport,
RCK_C is a domain used by Staphylococcus aureus (25,33,39,69). TetR-family transcriptional
regulators are another group of receptor proteins that were first found in M. smegmatis that
regulate stress response and membrane homeostasis (25,33). TetR-family transcriptional
regulators bind to DNA through a DNA-binding domain, an N-terminal TetR-like helix-turnhelix domain (25,33). This occurs after a structural change facilitated by stimulation by cyclicdi-AMP.
S. sputigena is hypothesized to have several TetR-family transcriptional regulators such
as SELSP_1770 and SELSP_1836 that interact and bind to cyclic-di-AMP. These are not the
only two possible TetR-family transcriptional regulators or effectors; however, they are the ones
that are being focused on. Finally, cyclic-di-AMP is degraded by phosphodiesterases, or PDEs,
into pApA (5’-phosphadenylyl-adenosine) (Figure 1-17) (25,33,65). GGDEF domain protein
containing PDE, or GdpP, has a DHH domain, a DHH associated DHHA1 domain, a PAS
sensory domain and a GGDEF domain (17,25,33). The PDE activity is contained within the
DHH/DHHA1 domains (17,25,33). The PAS sensory domain, when bound to heme, leads to
suppressed PDE activity, giving it a regulatory role (17,25,33). GdpP overall can hydrolyze
cyclic-di-AMP, for example, in B. subtilis (25,33,49). When DHH-DHHA1 domain, known for
its conserved DHH motif, and the PAS domain, known for its conserved Per-ARNT-Sim
proteins, are together in GdpP-type proteins, they are mainly found in the phylum Firmicutes
which S. sputigena is a part of (17,25,33,58). SELSP_2051 is the proposed phosphodiesterase
within S. sputigena that has DHH/DHHA1/PAS domains (17,25,33).
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Figure 1-6 Model of SELSP_1610 Full length Membrane Imbedded Domain
This is the predicted picture of the membrane-bound protein SELSP_1610, the projected
diadenylate cyclase, by PHYRE.
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Figure 1-7 Synthesis and Degradation of cyclic-di-AMP
This figure exhibits the synthesis of the secondary signaling molecule, cyclic-di-AMP,
from diadenylate cyclase, its interaction with target proteins, and finally its degradation
by phosphodiesterase with a DHH-DHHA1 domain into pApA.
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Selenomonas sputigena and cyclic-di-AMP
By studying Selenomonas sputigena, the hope is to be able to not only find a marker for
periodontal disease, but also find out if S. sputigena causes periodontal disease through virulence
factors that are regulated by cyclic-di-AMP. Based on bioinformatic analysis, we can make the
prediction that S. sputigena possesses a functional cyclic-di-AMP system that regulates these
pathogenic and physiological functions (3). The proposed genes listed above include
SELSP_2051, a phosphodiesterase, SELSP_1770 and SELSP_1836, TetR-family transcriptional
regulators, and SELSP_1610, a diadenylate cyclase, are the focus with a particular emphasis on
SELSP_1610. In addition, focus on potential virulence factors such as hemagglutination, biofilm
formation, and adhesion to gingival epithelial cells are also explored along with previously
unknown growth factors. These studies provide significant and new insights into this emerging
periodontal pathogen. This may highlight future strategies for the prevention and treatment of
periodontal disease.
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Chapter 2: Methods and Protocols
Standard Growth curve
A standard growth curve was started by inoculating an overnight 10ml culture of
Selenomonas sputigena in tryptone-yeast extract-gelatin-volatile fatty acids-serum (TYGVS)
media from frozen stocks. This starter culture was used to inoculate a secondary culture
overnight the following day. On the third day, two cultures were inoculated of 10ml TYGVS
media and two cultures of S. sputigena media simultaneously at a starting OD600 of .05. All
media was pre-reduced for at least 8 hours in the anaerobic chamber prior to use. The culture was
incubated and measurements of optical density at OD600 were taken every hour for ten hours to
establish a growth curve.

Plate Count
An overnight culture was grown from either a frozen stock or a maintained culture of
Selenomonas sputigena. The OD600 was checked the following day and the culture was brought
to an OD600 of 1. A 1:10 serial dilution of this culture was completed ten-fold and 100μl of each
dilution, 10-5 to 10-9, was plated in triplicate on pre-reduced TYGVS plates using proper aseptic
technique. The plates were incubated at 37°C for 4 days and the colonies were counted and
recorded at the end of the incubation.

Oxygen resistance
An overnight culture of S. sputigena was grown, brought to an OD600 of 1, and allowed to
incubate on a shaker in either anaerobic conditions or aerobic conditions for 4hrs prior to being
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plated. As aligned with the plate count protocol, serial dilutions were performed and 10-3, 10-4,
and 10-5 were plated on TYGVS plates.
Hemagglutination/Hemolysis assay
In order to check if S. sputigena agglutinated red blood cells, a hemagglutination assay
was performed. An OD600 of 1 is equal to 1.0x109 cells per ml, which was found previously
through colony counts, allowed for the starting calculation of an OD600 of .470, or 4.70x108 cells
per ml. Erythrocyte suspension prep was completed by gently mixing blood to suspend
erythrocytes and transfer .2 ml of blood to 4.8 ml 0.05M Tris-HCL buffer pH 7.5 containing
0.15M NaCl (TBS). This results in a 2% suspension of human erythrocyte based on a hematocrit
of about 50%. The gently mixed 2% suspension was centrifuged at 2000 rpm for 10 minutes at 4
°C. Two washes were performed in 5 ml of TBS and centrifuged at 500 g for 8 minutes. A 1:2
serial dilution was performed with a total of 50 μl within each of 12 wells of the 96 well V
shaped microtiter plate. The 12th well was blank with just erythrocytes and each dilution is
completed with TBS. The plates were left at 4°C to equilibrate for at least an hour and then 50μl
of the washed 2% erythrocyte suspension was added to each well. The plates were tapped to mix
the suspension. Plate 1 was left at 4°C to measure hemagglutination and plate 2 was left at 37°C
to measure hemolysis for four hours. The plate was covered to prevent evaporation.

Biofilm assay
In order to see if S. sputigena forms a monospecies biofilm, a culture of 5mls was grown
overnight. In addition, P. gingivalis was also grown as well as a positive control. It was diluted
from an OD600 of 1, 1:2 fold in a 96 well plate with a total of 100μl per well with 4 replicates.
The plate was incubated in the anaerobic chamber at 37°C for 4 hours, 24 hours, and 48 hours.
27
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After the timepoints were met, the plates were dumped out and submerged in water to wash
twice. 125μl of 0.1% solution of crystal violet in water were placed into each well of the plate
and incubated for 15minutes covered at room temperature. The plate was submerged again in
water 3 times, blotted on paper towels, and dried overnight. 30% of acetic acid in water was
added to each of the wells with a total of 125μl per well and incubated for 15 minutes. It was
then transferred to another flat bottomed 96 well plate. The absorbance was to be read at 550nm
with a blank. It was repeated once with paraformaldehyde in an attempt to fix the cells prior to
the washes.
4% paraformaldehyde solution in 1xPBS was added to the wells after the initial media
was carefully removed. The plate was incubated for 15minutes at room temperature. The plate
was submerged and washed twice prior to the addition of crystal violet to the wells. Another 15minute incubation occurred, the plate was blotted and dried overnight.

Epithelial cell Adhesion assay: TIGK cells
S. sputigena adhesion to oral epithelial cells is yet unknown, so an adhesion assay was
performed in order to test this. Telomerase-immortalized gingival keratinocyte (TIGK) cells
were seeded in half of a black 96 well plate and the other half of the plate was left empty. S.
sputigena was grown up in a 10ml culture in TYGVS media in the anaerobic chamber the night
before. The culture was spun down at 5000g for 5 minutes and adjusted to 2 ml per 1OD600 in
2mls of PBS. A working concentration of BacLight Green was used to stain, as per the
manufacturer’s protocol. The cells were spun down and washed with 2mls of PBS to remove
unbound BacLight. A serial dilution of S. sputigena cells were performed into PBS and 100μl of
cells were added per well. The plate was incubated at room temperature, covered in foil, and

28

Keller
rocked for 1 hour. The remaining bacteria is removed by washing the wells 5 times with 100mls
of PBS per well leaving the final wash in the wells. It was then imaged using a fluorescence plate
reader.

Antibiotic Sensitivity
In order to establish bacterial OD600 and be able to figure out when S. sputigena is
suppressed in the presence of particular antibiotics, bacterial resistance to different antibiotics at
different concentrations was a necessity. Ampicillin, Erythromycin, and Chloramphenicol were
chosen first. A starting culture of S. sputigena was grown in TYGVS media overnight and was
used to inoculate another overnight culture. 1ml of this overnight culture was used to inoculate
the tube. Stock solutions of each antibiotic were created at 50mg/ml and 10μl, 5μl, 2.5μl, 1μl
were each added to their corresponding 10ml culture. One culture was left without any
antibiotics. Each OD600 was measured at a 4hr timepoint.
This was repeated in duplicate with the two most promising antibiotics: Ampicillin and
Erythromycin. A stock solution of 100mg/ml was made for both. Of the stock, 10μl and 5μl of
Ampicillin and 75μl, 50μl, and 25μl of Erythromycin were added, respectively. The 10ml
cultures grew from an OD600 of .05 and final OD600 was recorded at 4 hours.

29

Keller

Cloning
Gene
SELSP_1610
full length
SELSP_1610
Truncated
SELSP_2051

SELSP_1770

SELSP_1836

Product domains
and Description
Diadenylate Cyclase

Sequence size

Protein size

834 nucleotides

30.86 kilodaltons

Diadenylate Cyclase
missing membrane
domain
DHH/DHHA1/PAS
Phosphodiesterase

537 nucleotides

19.49 kilodaltons

2034 nucleotides

75.18 kilodaltons

TetR-family
transcriptional
regulator
TetR-family
transcriptional
regulator

624 nucleotides

23.46 kilodaltons

561 nucleotides

21.24 kilodaltons

Table 1. Selenomonas sputigena genes
This table shows the genes, SELSP_1610, SELSP_2051, SELSP_1770, and SELSP_1836, that
were successfully cloned from Selenomonas sputigena. SELSP_1610 was truncated and cloned
again, as seen above. Each are listed with their domains and descriptions, their sequence size,
and their protein size as a reference.
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Primer design and PCR
The cloning process was started when the original sequence for S. sputigena, found on
the Kyoto Encyclopedia of Genes and Genomes (KEGG), was used to create primers for the
desired protein sequences. The chosen sequences: SELSP_1836 and SELSP_1770, both TetRfamily transcriptional regulators, SELSP_2051, DHH/DHHA1/PAS domain, and SELSP_1610, a
Diadenylate cyclase, from Selenomonas sputigena. Primers were designed an annealing
temperature of 55°C. The forward primer was designed with an overhang from the pLATE52
vector on the 5’ end, and the reverse compliment was taken for the reverse primer and the
reverse primer was added on the respective 5’ end.
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Primers
pLATE52
Vector
overhangs
LIC
Sequencing
primer
SELSP_1836

Forward
5’-GGT TGG GAA TTG CAAinsert sequence- 3’

Reverse
5’-GGA GAT GGG AAG TCA TTAinsert sequence-3’

TAATACGACTCACTATAGGG-

GAGCGGATAACAATTTCACACAG
G-

GGTTGGGAATTGCAAATGG
ACAGACGACAGAAAAAGAC-

GGAGATGGGAAGTCATTAGAGA
ATCGGCTCGATCACG-

SELSP_1770

GGTTGGGAATTGCAAATGG
AAGAAGAGAAGATAAGCCG
AGGTTGGGAATTGCAATTGC
CCCGAAATCTGTCGGGTTGGGAATTGCAAATGC
CGTTCCATATTCCGATTCGGTTGGGAATTGCAACAGG
GACGCTTCTTCGG-

GGAGATGGGAAGTCATTATTCC
TTTTGTTCTTCCTGCTTTTC-

SELSP_2051
SELSP_1610
SELSP_1610
Truncated

GGAGATGGGAAGTCATTACCCT
TGCTTCCGACCTTCGGAGATGGGAAGTCATTATTTC
CCCTTCCTCCAATTCAGGGAGATGGGAAGTCATTATTTC
CCCTTCCTCCAATTCAG-

Table 2. Primer design
This table shows the design of both the forward and the reverse primer pairs for each of the
genes that were cloned from S. sputigena. The first shows the forward and reverse overhang for
the pLATE52 vector. The second exhibits the primers used during sequencing.
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The overhang forward primer and the overhang reverse primer can be seen in Table 2. S.
sputigena was used as template DNA. Template gDNA was prepared by boiling S. sputigena in
water for 10minutes. PCR protocol for Phusion, high-fidelity DNA polymerase, was run for all
constructs with their respective forward and reverse primers. SELSP_2051 only worked with
Touchdown PCR program. This program relies on the gradual decrease of annealing temperature
until the desired annealing temperature is reached. It is decreased by 1-2°C each second until the
annealing temperature of the primers has been reached. All products were run on an 8% agarose
gel and photographed with the correct ladder: either 100kb DNA ladder from New England
Biolabs (NEB) or 1000kb DNA ladder from (NEB). Each DNA band was compared to its known
size respectively to make sure they were correct (Table 2).
Each band from the gel was imaged, cut out, and purified twice using Monarch Kit for
gel extraction and purification (NEB). The concentration was found using a nanodrop. The
resulting product was then ligated into the pLATE52 vector using the recommended amount of
purified product from aLICator ligation independent cloning and expression system kit from
Thermo scientific with an N-terminal His-tag. The transformation following the ligation was
performed into competent cells: E. coli: Nova Blue (DE3) cells. Within 24 hrs, the colonies were
taken, plated, and labeled in a grid on ampicillin plates to keep each colony organized. The
colonies were grown for 14 to 16 hours and standard minipreps were performed the following
morning. The plasmids were isolated and purified. The plasmids were sequenced by Genewiz
using the LIC forward and reverse primers (Table 2). It was then compared with the original
sequence found on KEGG to confirm their accuracy.

33

Keller
Protein Induction
Protein induction followed. Colonies were chosen from the corresponding correct
sequences and were added to an overnight culture (LB ampicillin). It was grown at 37°C in a
shaker (14 and 16 hours). The OD600 was checked at the end of the incubation. A 500 ml culture
of LB broth with (1/1000) ampicillin from a 100 mg/ml stock was brought up to an OD600 of .05
and grown until the OD600 was between .400 and .600. A sample was taken and resuspended
with SDS page buffer. 500μM of IPTG (isopropyl-beta-D-thiogalactopyranoside) was then added
to the culture to induce protein production for four hours. Cells were harvested at the four-hour
time point and another sample was taken and resuspended using SDS page buffer. This process
was completed for each respective protein. A control was used at the end of each protein
induction in the form of a Coomassie gel. Each sample of competent cells, pre and post IPTG,
were boiled and fractioned by SDS-PAGE. The gel was stained using Coomassie blue, and the
protein sizes were compared to the duel color standard protein ladder from Bio-Rad and known
sizes were found from the sequence (Table 1).
SELSP_1610 had a membrane bound domain that prevented the protein from leaving the
cell. This membrane bound portion reduced OD600 and resulted in no protein production. This
protein was modified to remove the membrane-bound domain in order to facilitate the expression
of the protein. The forward primer was redesigned (Table 2) to exclude the membrane-bound
domain. PCR was repeated, as stated above, and SELSP_1610 truncated was sequenced. With
the sequence confirmed, the truncated protein was induced again using IPTG. The Coomassie gel
run with the pre and post induction samples confirmed the protein expressed. The size was also
confirmed (Table 1).
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Homogenization and FPLC
All the pellets were spun down, the supernatant discarded, and the pellets were collected
and stored at -80°C until they were homogenized. The homogenizer used: 20mM imidazole,
20mM NaH2PO4, 500mM NaCl, and 1mg/ml lysozyme. The pellet was vortexed and pushed
through a high-pressure homogenizer. The protein was purified by metal affinity
chromatography using a Ni-NTA column. The crude lysate was washed out with the buffer and
high purity protein was eluted with imidazole. The purified protein was eluted into PBS with 50
mM glutamic acid and arginine.

Reverse Phase Chromatography
SELSP_1610 Enzymatic Assay
Both buffer A and buffer B were made the same week the reaction was going to be run.
Buffer A included 100mM KH2PO4, 4mM tetrabutylammonium hydrogen sulfate and the pH
was equalized to 5.9, and Buffer B included 70% Buffer A and 30% methanol (MeOH) , was
used to run the HPLC machine. Diguanylate cyclase buffer (DGC buffer) needed to be made
within two days of running the reaction. This buffer contained 10mM of an activating cation
chosen for the reaction, and the remaining compounds remained unchanging. The DGC buffer
contained 50mM Tris-HCL (pH 7.6), 0.5mM EDTA, 50mM NaCl. The suggested cations to use
in the literature were Magnesium, Manganese, and Cobalt (34). The conversion of ATP to
cyclic-di-AMP was to be tested using a reaction of the enzyme, truncated SELSP_1610, the
chosen cation within the DGC buffer, plus an excess of ATP incubated at 37°C for an hour. 5μM
of SELSP_1610 was added to the DGC buffer. 150μM ATP of a 10mM stock was used. 58.5μg
was needed of SELSP_1610. Overall, the total reaction volume was 600μl and of that, 97.5μl
was needed of SELSP_1610 along with 9μl of ATP. The reaction was incubated 37°C for an
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hour, boiled for 3 minutes to stop the reaction, and then centrifuged at 15,000g for 2minutes. The
sample was then filtered through a .22μM syringe filter and 20μl was loaded into the column.
Prior to the reaction being run through the HPLC column, a 600μl reaction of 9ul of ATP and
another 9μl of cyclic-di-amp should be run as controls in order to determine the elution profile of
each control molecule. The two controls that were initially used were ATP alone and cyclic-diAMP alone. The controls were to be run each time the reaction was run as they shift minutely per
run through the HPLC column and need to be compared to each respective reaction and buffer
used. It has also been suggested to run the c-di-AMP control post reaction as to mitigate any
false positives.
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Reaction
volume
Reaction set 1
600μl

Original protein
600μg/ml

1 hour

Amount
of ATP
added
9μl ATP

Reaction set 2
600μl

Original protein
600μg/ml

1 hour

9μl ATP

Reaction set 3
600μl,
300μl
200μl

Dialyzed protein
137μg/ml
Original protein
600μg/ml
Dialyzed protein
137μg/ml
Original protein
600μg/ml
Dialyzed protein
130μg/ml

1 hour,
1 hour,
2.5 hours

9μl ATP,
3μl ATP
3μl ATP

2 hours
1.5hours

9μl ATP

Reaction set 4
New column
600μl

Protein run
SELSP_1610

Incubation
Time

Cation

Buffer used

10mM
MgCl2

1x DGC buffer,
Elution 30%
MeOH
1x DGC buffer,
Elution 50%
MeOH
10x DGC buffer,
1x DGC buffer,
Elution 50%
MeOH

10mM
MgCl2
MnCl2
10mM
MgCl2
MnCl2

10mM
MnCl2

1x DGC buffer,
Elution 50%
MeOH

Table 3 Enzymatic Assay Variables
This table is a visual representation of all of the variables changed to improve this assay:
kinetics, stoichiometry, cations, and buffer concentrations with focus on the reaction volume, the
protein concentration, dialyzed protein vs original protein, incubation time, the amount of ATP
added to the reaction, and the cation of choice.
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This enzymatic assay began with the reaction run in 1xDGC buffer (table 3). Based on
the literature, the first activating cation was chosen (magnesium chloride at 10mM). This
reaction took the purified protein, truncated SELSP_1610, and added 58.5 μg (97.5μl), and an
excess of ATP at 150μM (9ul added) then brought up to a total volume of 600 μl with 1xDGC
buffer. The reaction incubated for an hour at 37°C, was boiled at 99°C and was processed as
previously described above. The two controls, ATP and c-di-AMP, were both run prior to the
20μl injection of the reaction run through the HPLC column and eluted with 30% MeOH. Due to
the fact that ATP was eluted and compared to the ATP peak, the experiment was repeated to
improve the assay (table 3). The controls were run every time to compare the products. Though
the baseline assay remained the same, following the protocol described above, different variables
were adjusted such as different choice in cation, change in stoichiometry, variation in kinetics,
and changes in other minute details to improve the assay.
.

The first variable changed was the cation added to the DGC buffer. Initially magnesium

chloride was used. The buffer was remade again using two cations instead of one, magnesium
chloride, and manganese chloride (10mM), and was repeated again. The last buffer was made
only including manganese chloride and excluding magnesium as the cation of choice based on
findings in the literature. In addition, dialysis was completed using the original protein over the
weekend at 4°C into 1xDGC buffer with magnesium and manganese, then overnight with
manganese alone. These reactions with the dialyzed protein were completed in addition to the
non-dialyzed original protein (table 3) to prevent phosphate inhibition from the original buffer.
More stoichiometric changes were made by reducing the total volume size of the reaction
from 600μl, to 300μl, to 200μl using both the dialyzed protein at both full volume and reduced
volume size (table 3). The addition of ATP was reduced along with the reaction size. The total
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concentration of the DGC buffer was increased to 10x, instead of 1x, as well (table 3). This was
only performed in one reaction. The next condition to be adjusted, in terms of kinetics, was the
reaction time.
The reaction time (incubation) started with, was 1hr. Over the course of these reaction
sets, the time was increased to 1.5hrs, 2hrs, and last 2.5hrs (table 3). In total, the combination of
changes in condition included reaction time, change in reaction buffer concentration, change in
protein concentration and reaction size, change in protein buffer, and change in cation of choice.
These were tried together in various combinations to reach a different outcome and improve the
assay (table 3). In addition, small changes were made to the assay such as thawing the protein in
water to preserve the integrity of the enzyme, changing the methanol elution from 30% to 50%,
running blanks to screen for background peaks, and using a new column. More time is needed to
change any other variable that may need to be adjusted to improve the assay.

Chapter 3: Results

Basic Characterization of Selenomonas sputigena
Though Selenomonas sputigena had been discovered a little over 6 decades ago to be
associated with fatal septicemia and found within the oral biofilm as a marker for periodontal
disease, it is considered to be an emerging oral pathogen. Its growth patterns in the laboratory, let
alone virulence factors as a potential pathogen, have yet to be truly defined within available
literature. There has been little to no basic background information or supplemental information
published on this organism. As it has not been looked at in detail to date, there is very little
starting material on S. sputigena. Due to this fact, the initial step was to begin with establishing
basic information on this anaerobic organism. Without defining the parameters of S. sputigena
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growth within the laboratory, there would be no solid foundation on which to begin this project.
In order to determine this, the project began with defining basic growth characteristics such as
proper growth media, a bacterial growth curve, plate counts, oxygen resistance, and finding
antibiotic sensitivity. Hemagglutination, hemolysis, monospecies biofilm development, and
adhesion to epithelial cells was also tested in addition.

Selenomonas sputigena Growth Characteristics
Growth Curve
The growth curve was meant to test two different types of growth media over the course
of 10 hours with measurement of OD600 every hour. The growth for S. sputigena media never
met the proper parameters for a growth curve and was excluded from all future attempts to grow
S. sputigena (Figure 3-1). The rate of growth was too low to use it as a viable option; however,
TYGVS media exhibited a classic growth curve. Exponential phase was reached between three
and six hours and the stationary phase followed at approximately seven hours. The doubling time
was calculated to be between 25-30 minutes (Figure 3-1) during the Log phase. The growth
curve, when repeated, should be extended past the ten-hour mark for a more complete picture of
bacterial growth. The stationary phase never entered the death phase; therefore, the time should
have been extended another 4 to 6 hours.
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Growth Curve

`
Figure 3-1 Growth Curve for Selenomonas sputigena
The growth curve began with an OD600 of .05. The growth curve was completed over the course
of 10 hours and was checked every hour. The lag phase happened between 0 and 3 hours. From 3
to 6 hours the exponential phase occurs and this leads into the stationary phase. The time needs
to be extended in order to show the death phase. The equation: Nt = N0*(1+r)t was used to
calculate the doubling time, which was discovered to be 25-30minutes.
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Plate counts
The plate counts were completed several times and have not been able to be replicated
successfully without some level of contamination on the plates, or inconsistencies with the number
of colony forming units. Consistent counts have been unexpectedly difficult to achieve because of
this. The most consistent results were the initial counts, which showed approximately 1.0x109 cells
per ml, (used in the hemagglutination assay) and the last plate count which is seen below in Figure
3-2. This experiment needs to be repeated three times with consistent counts on each plate, and no
contamination, to find a more accurate plate count and cells/ml. This, however, has given us a start
in order to complete more assays like the hemagglutination assay.
Plate count
Dilution
Plated
10-4
10-5
10-6
10-7
10-8

Number of
Colonies
2320, 2595, 2363
367, 356, 266
35, 16, 15
-,2,4
-,1,-

Average Colony
Count
2426 cfu
330 cfu
22 cfu
3 cfu
1 cfu

Cells/ml
2.4 x 108
3.3 x 108
2.2 x 108
3.0 x 108
1.0 x 108

Figure 3-2 Plate counts
This table shows the plate counts for Selenomonas sputigena grown over
the course of four days. Each plate was counted and the cells per ml were calculated
from the known colony forming units and starting OD600 of 1. The average calculated for
cells/ml was 2.4 x 108.
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Oxygen Resistance
Oxygen resistance was repeated by another member of the lab. S. sputigena plated in
anaerobic conditions mirrored the plate counts grown previously (Figure 3-3) with 1.7 x 108
cells/ml calculated. The aerobic conditions exhibited no colony formation on the plates. This
indicates that Selenomonas sputigena has little to no oxygen resistance and cannot grow in an
oxygen rich environment. The question is: at what point does growth slow, stop, and result in the
death of the S. sputigena colony. A more detailed test would be needed, perhaps with more
timepoints for plating.
Oxygen Resistance Plate Counts
Dilution Plated
Anaerobic
10-3
10-4
10-5
Aerobic
10-3
10-4
10-5

Number of Colonies

Average Colony Count

TNTC
TNTC
206, 168, 137

170

No Colonies
No Colonies
No Colonies

-

Figure 3-3 Plate Counts for Oxygen Resistance
This table exhibits the data for the plate counts done in both anaerobic conditions and aerobic
conditions. The anaerobic conditions mirror the previous plate counts with an average cells/ml of
1.7 x 108 cells/ml and too many colonies to count for the first two dilutions. The aerobic
conditions resulted in no colonies plated, indicating S. sputigena is not resistant to the presence
of oxygen.

43

Keller

Antibiotic Sensitivity
Antibiotic sensitivity needed to be studied in order to begin the cloning process. Without
knowing what type of antibiotic to use, choosing the cloning vector would not be possible. Three
types of antibiotics were used: ampicillin, erythromycin, and chloramphenicol. Initially, because
little to no information exists on antibiotic sensitivity with Selenomonas sputigena, a broad
spectrum of types and concentrations were used. 50μg/ml, 25μg/ml, 12.5μg/ml, and 5μg/ml of
each were added, complete with two blanks and two cultures grown without (Figure 3-4). This
was just an initial test to see where to begin. It was then narrowed down to erythromycin and
ampicillin and was repeated. The bacterial culture was started at an OD600 of 0.05 this time and
allowed to grow for 4hrs. The amount of erythromycin added was increased to 750μg/ml,
500μg/ml, 250μg/ml and ampicillin with 100μg/ml and 50μg/ml (Figure 3-5). The blank and the
culture without antibiotics were also run again.
The initial round was used as a starting point to narrow down the choice of antibiotics. It
was evident that ampicillin reduced the OD600 greater than any other of the chosen antibiotics. It
was then replicated, and the second round was more specific and focused on the last two
antibiotics that would be a viable option. This was repeated one last time before ampicillin was
the chosen antibiotic, as it was shown to reduce OD600 when compared to the culture without
antibiotics. Ampicillin, at the concentration of 100μg/ml, was found to be the most effective
antibiotic as Selenomonas sputigena showed sensitivity to it and the total OD600 was decreased
(Figure 3-5). This was the chosen concentration that was used throughout the cloning process.
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Initial Antibiotic Sensitivity

OD600

Selenomonas sputigena Antibiotic Sensitivity
0.1
0.09
0.08
0.07
0.06
0.05
0.04
0.03
0.02
0.01
0

Antibiotics and Concentration

Figure 3-4 Antibiotic Sensitivity Initial
This bar graph exhibits the initial antibiotic sensitivity panel chosen with concentrations of
50μg/ml, 25μg/ml, 12.5μg/ml, and 5μg/ml for ampicillin, chloramphenicol, and erythromycin.
The optical density was recorded after 4 hours and ampicillin appears to have reduced the OD600.
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Antibiotic Sensitivity Replicate

OD600

Selenomonas sputigena Antibiotic Sensitivity
0.5
0.45
0.4
0.35
0.3
0.25
0.2
0.15
0.1
0.05
0

Antibiotics and Concentrations

Figure 3-5 Antibiotic Sensitivity
This bar graph shows the application of 750μg/ml, 500μg/ml, 250μg/ml of erythromycin and
100μg/ml and 50μg/ml of ampicillin. For this experiment, the cultures were started with an
OD600 of 0.05. The optical density was taken again at four hours. Ampicillin, at the concentration
of 100μg/ml, was found to be the most effective and was used throughout the cloning process.
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Selenomonas sputigena Virulence Factors
Hemagglutination Assay
Hemagglutination, or the ability to bind to erythrocytes, and hemolysis, the lysing of
erythrocytes, was the next thing that was tested with the help of the Jefferson lab. As
Selenomonas sputigena is considered to be an emerging oral pathogen, its virulence factors also
have yet to be defined as much as its growth capabilities. This was the first concrete step taken to
find S. sputigena virulence factors in the lab. This assay would indicate if S. sputigena has the
capability to bind to and lyse human erythrocytes. If hemagglutination and hemolysis of
erythrocytes occurs, it is a good indication that Selenomonas sputigena not only has pathogenic
capabilities but also have virulence factors that facilitate them as well. Checking if S. sputigena
can agglutinate and lyse red blood cells would have allowed for more specific studies of this
virulence factor. Human erythrocytes were used and S. sputigena was grown in an overnight
culture. A 1:2 dilution was performed on a 12 well plate with a control with only erythrocytes in
well 12 (Figure 3-6). Both incubation at 4°C, to study agglutination, and 37°C, to study
hemolysis, were chosen. Had the results been positive for hemagglutination, S. sputigena would
have bound the erythrocytes in a lattice, and the blood would have been uniform in the well. Had
the results been positive for hemolysis, the buffer would have become red with a pellet in the
bottom. However, the wells were negative for all the dilutions. The condensed pellet at the
bottom indicating negative results corresponded with the negative control in the last well (Figure
3-6). This indicates that Selenomonas sputigena does not agglutinate or lyse red blood cells. This
could be repeated with different conditions: aerobic vs anaerobic.
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Hemagglutination assay
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Figure 3-6 Hemagglutination/Hemolysis Assay
This figure is a picture taken of the first and second 96 well plate at the 4-hour time point. Well
12 is the negative control used for both incubation at 4°C (Hemagglutination) and 37°C
(Hemolysis). This indicates that neither hemagglutination nor hemolysis has occurred.
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Biofilm Development
Selenomonas sputigena monospecies biofilm development would indicate the presence
and use of this as a virulence factor. Pathogenic bacteria in the oral cavity form an intricate
overlay, interacting not only with other pathogens, but also commensal bacteria as well. Many
species form both monospecies biofilms as well as polymicrobial biofilms to incite disease. They
can interact with each other and can increase other virulence factors to cause disease.
Porphyromonas gingivalis is a known oral pathogen that forms a biofilm, not only with itself,
but with other oral pathogens like F. alocis (5). It is unknown if Selenomonas sputigena forms a
biofilm with other pathogens as well as if it forms a monospecies biofilm. This assay performed
was to study a monospecies biofilm for S. sputigena.
The assay was performed four times, and each time it resulted in an empty plate. P.
gingivalis was used as the positive control. It was probable that the harsh washes cleared the cell
layer completely, even though one plate was fixed first. The supernatant should have been taken
off, and the wells washed gently. Another possibility is that S. sputigena should have been
stressed first. Biofilms can and do also form under stressed conditions as well. This assay could
be performed again by stressing both the positive control and S. sputigena. Either S. sputigena
does not form a biofilm with itself, or the assay was incomplete and needs modification. The
latter seems to be the case. As P. gingivalis did not appear on the plate either, this indicates that
the assay needs to be developed more before it can work. It could also be the fact that
Selenomonas sputigena does not form a biofilm with itself, but it interacts with other pathogens
to form biofilms. The monospecies biofilm assay should be perfected and tried again with
another protocol and it should be tried with other known oral pathogens to see if it interacts and
forms polymicrobial biofilms.
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TIGK Adhesion Assay
Selenomonas sputigena adhesion to gingival epithelial cells was looked at in this assay
and has been replicated successfully. The graph illustrates the adhesion of S. sputigena to
telomerase-immortalized gingival keratinocytes, or TIGK cells (Figure 3-7). S. sputigena was
added in a series of dilutions to the first four rows. The last four rows were TIGK cells alone.
The average background fluorescence in the non-infected wells was subtracted from the average
fluorescence of the infected wells. This allowed for the fluorescence to be analyzed without the
possibility of background changing the data. The data in Figure 3-7 indicates that S. sputigena
does adhere to TIGK cells. Adhesion to epithelial cells is another indicator that S. sputigena
possesses virulence factors that contribute to bacterial pathogenesis. This not only allows for the
colonization of this bacteria through adhesion to the host cells but can also contribute to biofilm
development. This is not only an indication that S. sputigena possesses this virulence factor and
provides a direction to study adhesion, but also indicates that the biofilm assay should be revised
and repeated.
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Selenomonas sputigena Adhesion Assay: TIGK cells

Adhesion Assay: TIGK cells
25000

Fluorescence

20000
15000
10000
5000
0
1

2

3

4

5

6

7

8

Dilution of S. sputigena (through well 8)

Figure 3-7 Selenomonas sputigena Adhesion Assay: TIGK cells
Once the background fluorescence from the TIGK (telomerase-immortalized gingival
keratinocyte) cells was removed from the average, the remaining fluorescence was noted in this
graph. The wavelength with which it was measured was 485nm/535nm. This indicates that
Selenomonas sputigena does adhere to epithelial cells showing that it has potential virulence
factors that lead to adhesion and interaction with the gingival epithelium.

51

Keller
Cyclic-di-AMP Metabolism in Selenomonas Sputigena
The focus was eventually shifted from microbial analysis in a laboratory environment to
molecular and biochemical analysis of its potential synthesis, use, and degradation of the
secondary messenger cyclic-di-AMP. All PCR products were run on agarose gels and the size
was checked (Figure 3-8). SELSP_1836 and SELSP_1610 full length were easily PCR
amplified. SELSP_1770 did not work until after the forward primer was redesigned and
SELSP_2051 did not work with conventional PCR and only worked with touchdown PCR. This
factor may have been contingent upon the size of the amplified product. The cloning process was
completed, and the proteins successfully induced and purified (Figure3-9). The genome of S.
sputigena was already sequenced and added to databases; however, certain genes have not been
established in terms of their function. They can only be surmised by comparison to other known
genes from other established microorganisms. The functions of SELSP_1810 and SELSP_1770
were hypothesized to be TetR-family transcriptional regulators, the function of SELSP_2051 is
hypothesized to have DHH/DHHA1/PAS domains and has phosphodiesterase activity, and the
main focus of this section is SELSP_1610, a hypothesized diadenylate cyclase.
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PCR products

Figure 3-8 PCR Products
The bands for each group that are side-by-side are replicates of the same reaction. SELSP_1836
at 561bp, SELSP_1610 full length at 834bp and truncated at 537bp, and SELSP_1770 at 537bp
were all strong bands. SELSP_2051 at 2034bp included intense primer dimer bands and was
eventually amplified with Touchdown PCR as seen in lane 5.
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SDS Page gel

Figure 3-9 Coomassie Stain Protein Induction
This Coomassie gel shows the remaining induction of SELSP_2051 at 75.49 kilodaltons and
SELSP_1770 at 23.46 kilodaltons. SELSP_1610 truncated was induced again to isolate more
protein. SELSP_1836 can be viewed in Figure 3-10.
.
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Enzyme Assay: SELSP_1610 cyclic-di-AMP
In addition to establishing basic growth conditions and beginning to find possible
virulence factors for Selenomonas sputigena, an assay to study synthesis of cyclic-di-AMP in S.
sputigena was developed using HPLC. We can make the prediction that S. sputigena possesses a
functional cyclic-di-AMP system based on bioinformatic analysis. This suggested pathway
regulates pathogenic and physiological functions within S. sputigena. The proposed diadenylate
cyclase that was the focus of this assay was SELSP_1610. During the cloning process,
SELSP_1610 had to be truncated due to prevention of protein induction due to the membranebound domain (Figure 3-10). Once truncated SELSP_1610 was successfully induced and
purified, the next step was to find evidence to support that the purified protein acts as a
diadenylate cyclase. SELSP_1610 was a match with other diadenylate cyclases for protein
structure and, because of this, it was thought to have potential DAC activity and was
hypothesized to convert ATP into cyclic-di-AMP.
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IPTG protien indiuction of SELSP_1610

Figure 3-10
The Coomassie gel to the left shows the induction of SELSP_1610 side by side with the
induction of SELSP_1836. SELSP_1836 was expressed with IPTG and appeared at 21.24
kilodaltons. When the membrane domain of SELSP_1610 was removed, the protein was induced
and appeared on the gel to the right at 19.49 kilodaltons.
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The amino acid sequence that was found on KEGG, matched with other transferases, and
fit in the category of diadenylate cyclase within the KEGG orthology as a conserved hypothetical
protein, CHP00159 (DacA diadenylate cyclase). BRITE hierarchy also confirmed this enzyme as
a potential DacA diadenylate cyclase within Selenomonas sputigena. The amino acid sequence
was run through NCBI blast and came back with similarity to diadenylate cyclase and within S.
sputigena as a TIGR00159 family protein. The other sole fully sequenced selenomonad,
Selenomonas ruminantium also has diadenylate cyclase (SFH94163.1) that has a similar structure
to SELSP_1610 within S. sputigena. In addition, a model of the protein needed to be constructed
and compared to other known sequences to further build evidence that SELSP_1610 had
potential DAC activity and can be considered to be a diadenylate cyclase.
The known amino acid sequence from KEGG was run through both PHYRE and SWISSmodel with both the truncated version and the full-length version. The focus, as the truncated
version was what was used for the reaction, was the truncated version of SELSP_1610 that began
with the membrane domain removed. The amino acid sequence was run through both modeling
programs and the monomers from both were compared and found, not only to have similar
structure, but were both considered to be a diadenylate cyclases when compared to other
templates (Figure 3-11).
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Truncated SELSP_1610 Model

Figure 3-11 Truncated SELSP_1610 SWISS-model vs PHYRE model
The protein structure on the left is a model created by SWISS-model of the potential
conformation of truncated SELSP_1610. The other model to the right was created by a similar
protein modeling database called PHYRE which also created a potential model for truncated
SELSP_1610. As seen comparatively, both models are similar to each other. This denotes the
fact that, as it matches up to other enzymes that contain DAC activity, this protein could be
considered a diadenylate cyclase.
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Confidence Model of Truncated SELSP_1610 PHYRE

Figure 3-12 Confidence Model of Truncated SELSP_1610 PHYRE
This model of truncated SELSP_1610, the potential diadenylate cyclase, shows the confidence
score when it comes to the structure created by PHYRE. This model was created with 88% of the
residues modelled and greater than 90% confidence. The removed membrane portion seems to be
the area of least confidence.
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Confidence Model of Truncated SELSP_1610 SWISS-model

Figure 3-13 Confidence Model of Truncated SELSP_1610 SWISS-model
This homodimer model of truncated SELSP_1610, the possible diadenylate cyclase, was created
by the SWISS-model. This model also shows the areas of most confidence in blue to least
confidence in red. As with the model from PHYRE, the areas of least confidence were the
removed membrane portion. When compared to other templates, this protein was suggested to
have DAC activity. The active site and interaction with cations are in the middle.
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PHYRE was found to have 88% total coverage with greater than 90% confidence (Figure
3-12). The SWISS-model had a positive QMEAN score of .29 with a loss of confidence near the
cutoff point of the protein where the membrane domain had been removed (Figure 3-13). Both
models together, when compared to other templates, point to SELSP_1610 being a membranebound enzyme that falls under the category of nucleotide transferases and matches other
diadenylate cyclases from other bacteria such as Staphylococcus aureus and Listeria
monocytogenes (35,58,69,72). Though there are different types of diadenylate cyclase, SWISSmodel suggested that the top two types of diadenylate cyclase that SELSP_1610 truncated
mirrored, were CdaA, cyclic di-AMP synthase A, in Listeria monocytogenes and DacA,
diadenylate cyclase A, in Staphylococcus aureus (35,58,72). Both have different nomenclature
for the same enzyme: diadenylate cyclase. It is also the type that is conserved in Firmicutes, the
phylum that S. sputigena is a part of. It can then be hypothesized that the function would be the
same as well.
A detailed matching of suggested motifs within SELSP_1610 was also run as well to look
for activation sites and binding motifs. A glycosylation site, protein kinase phosphorylation site,
and myristoylation sites were all found. SELSP_1610 also has conserved RHR and DGA motifs
which are responsible for ATP binding (59). To test the function of SELSP_1610, HPLC for
Reverse Phase Chromatography was used. It had previously been used to study diguanylate
cyclase in detail, but not diadenylate cyclase. Due to this fact, developing an assay through
reverse phase chromatography using HPLC (High Performance Liquid Chromatography) was the
concentration of this experiment and would be the chosen method to test this particular
hypothesis.
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Initially, primers for the original sequence for SELSP_1610 in its entirety were designed
and an attempt at induction of the full-length protein occurred (Figure 3-10). This resulted in no
production of SELSP_1610 as the protein is a membrane-bound protein. The membrane-bound
portion did not allow for the production of this protein and only resulted in the drop of OD600 as
the competent cells died instead. A new approach was taken, and the primers were redesigned to
remove the first portion of the protein sequence, effectively removing the membrane-bound
domain. This was then used as the protein, a truncated SELSP_1610, that was able to be
expressed during protein induction. The hypothesis was that the truncated SLESP_1610 would
have DAC activity, and within the literature, there were several suggested activating cations in
order to facilitate the reaction with ATP that forms cyclic-di-AMP. The suggested cations were
Magnesium, Manganese, and Cobalt (34). Through the help of the Marconi lab, a protocol that
was previously used for looking at diguanylate cyclase and converting GTP to cyclic-di-GMP
was already provided. This protocol however, had not been used to study diadenylate cyclase
activity.
The initial reaction began with building the potential assay by choosing magnesium
chloride as the first cation that was added to the 1x DGC buffer. Magnesium was chosen as both
one of the cations recommended in the literature and one that had been used successfully in the
cyclic-di-GMP study. The protein was thawed on ice prior to setting up the reaction that was run
for one hour with 9μl of ATP. The controls, both ATP and c-di-AMP, were both run before the
reaction was run and the recommended elution percentage of methanol used was 30%. The peak
for ATP was eluted at 16 minutes and cyclic-di-AMP was eluted at 18 minutes with some
background. When 20μl of the 600μl reaction was run through the HPLC machine, there was
more background and an unknown peak. In addition, there was a peak that was eluted at 16
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minutes indicating that ATP was eluted and not cyclic-di-AMP (Figure 3-14). The next reaction
needed to be adapted as the primary reaction set did not work.
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Reaction Set 1

Figure 3-14 Reaction Set 1 for SELSP_1610: Magnesium
Reverse Phase Chromatography was run on an HPLC column. The first two graphs are controls
featuring ATP alone with a peak eluted at 16 minutes in the first and cyclic-di-AMP run alone
with a peak eluted at 18 minutes on the second. The third following was the first reaction set up
with SELSP_1610 truncated, an excess of ATP, incubated for 1hr with 1xDGC buffer containing
magnesium as the cation. The peak was eluted at the ATP mark: 16 minutes.
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The second reaction set was changed so that it included two of the known activating
cations found within the literature: magnesium chloride and manganese chloride. Every other
aspect remained the same other than the elution percentage of methanol which was increased to
50% because it was suggested in another reverse phase chromatography protocol. Two blanks
were run prior to running the control, cyclic-di-AMP, through the column in order to clear any
potential background. Both blanks had background peaks, and when both the control and the
reaction were run, they too had background peaks. Cyclic-di-AMP eluted at 16.5 minutes and the
reaction that was run with the same conditions as reaction set 1 and was eluted at 14.5 minutes
(Figure 3-15). This indicates that the product that was eluted was ATP and not cyclic-di-AMP.
For the third reaction set, several variables were changed.
Reaction Set 2
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Figure 3-15 Reaction Set 2 for SELSP_1610: Magnesium and Manganese
Reverse Phase Chromatography was run on an HPLC column. The first two graphs are blanks to
clear the column. The third is a cyclic-di-AMP control run alone with a peak eluted at
16.5minutes. The fourth following was the first reaction set up with SELSP_1610 truncated, an
excess of ATP, incubated for 1hr with 1xDGC buffer containing magnesium and manganese as
the cation. The peak was eluted at the ATP mark: 14.5minutes.
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The cations chosen for the third reaction set were the same as reaction set two:
magnesium chloride and manganese chloride. The original purified protein, truncated
SELSP_1610, was dialyzed with the 1xDGC buffer containing both cations. This replaced the
original buffer with the reaction buffer in an attempt to prevent phosphate inhibition of the
reaction. After the protein was left in the buffer over the weekend, crashed out of solution, and
resuspended, the new concentration was found. This may be why this reaction did not work.
ATP was run as a control before the rest of the reactions were run with an elution peak at 12.5.
The dialyzed protein reaction was run for 1 hour with ATP with a 600μl reaction volume and a
10xDGC buffer that was made earlier that week. The peak that was eluted denoted ATP elution.
For the next reaction, the reaction volume size was changed to 300μl and the original protein,
that was thawed on ice, was used along with 1xDGC. ATP was eluted again at 12.5 minutes.
Cyclic-di-AMP was run as a second control after this reaction was run and eluted at 14.5
minutes, then a blank was run to make sure it had cleared the HPLC column. The last reaction of
the day used the last of the dialyzed protein and a reduced reaction volume size, 200μl in total,
with 1xDGC buffer and 3μl of ATP was used. The reaction incubation time for this run was
increased to 2.5hours. ATP was eluted again at 12.5 minutes (Figure 3-16).
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Reaction set 3
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Reaction set 3 continued

Figure 3-16 Reaction Set 3 for SELSP_1610: Magnesium and Manganese
Reverse Phase Chromatography was run on an HPLC column. The first graph is a control
featuring ATP alone with a peak eluted at 12.5 minutes. The second and third exhibit the reaction
of dialyzed protein at 600μl in 10xDGC buffer and the original protein in the original buffer but
reduced to 300μl. Cyclic-di-AMP run fourth alone with a peak eluted at 14.5minutes. The
following was a blank and the last run is 200μl with dialyzed protein for 2.5 hours 1xDGC buffer
containing magnesium and manganese as the cation was used. The reaction peaks were all eluted
at the ATP mark: 12.5 minutes.
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For the fourth reaction set, the other variables for each of the other reactions were taken
into consideration. The activating cation was changed, the methanol elution concentration was
increased, and then dialysis was performed on the original protein into the new buffer. After this,
the buffer concentration was varied between 1x and 10x DGC, the reaction volume size was
decreased for both the original protein and the dialyzed protein along with ATP added, and the
kinetics were changed as well by increasing the incubation time. In addition, a new column was
used on the HPLC machine. For the fourth reaction set, the two variables that were changed were
the chosen cation and the incubation time. Manganese was chosen as the only cation and the new
incubation times chosen were 2 hours and 1.5 hours. After further literary analysis, it had been
suggested in the literature that some DAC activity was inhibited by magnesium (35,58). This
applied to CdaA, cyclic di-AMP synthase A, in Listeria monocytogenes and DacA, diadenylate
cyclase A, in Staphylococcus aureus (35,58). As SELSP_1610 mirrors both of these proteins,
magnesium was eliminated from the buffer and a new buffer was made.
The buffer was remade with manganese as the sole cation and the dialysis of
SELSP_1610 was completed again overnight into the new buffer. The protein crashed out of
solution again and the concentration was found again. The original protein was thawed in room
temperature water to facilitate thawing all at once so the buffer would not affect the enzyme,
then it was stored on ice prior to the reaction. Both ATP and cyclic-di-AMP were used as
controls prior to the 2hour reaction that was run. ATP eluted at 12.5 minutes and cyclic-di-AMP
eluted at 14.5 minutes. The two-hour reaction that was incubated with the original protein
thawed in room temperature water was eluted with an ATP peak. The second reaction was
incubated for 1.5hours with the newly dialyzed protein (Figure 3-17). This product was also
eluted at the ATP peak.
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Reaction set 4
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Reaction set 4 continued

Figure 3-17 Reaction Set 1 for SELSP_1610: Manganese
Reverse Phase Chromatography was run on an HPLC column. The first two graphs are controls
featuring ATP alone with a peak eluted at 12.5minutes in the first and cyclic-di-AMP run alone
with a peak eluted at 14.5 minutes on the second. The third following was the first reaction set up
with SELSP_1610 truncated original protein, an excess of ATP, incubated for 2.5hrs with
1xDGC buffer containing manganese as the cation. The final reaction with SELSP_1610
truncated dialyzed protein, an excess of ATP, incubated for 1.5hrs with 1xDGC buffer
containing manganese as the cation. The peaks were eluted at the ATP mark: 12.5 minutes.
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Chapter 4: Discussion
Over the course of this project, Selenomonas sputigena has been studied and evaluated as
an emerging oral pathogen in a novel way. Prior to this study, it has not been thoroughly
explored within the literature. Within this project, the growth factors for S. sputigena have been
fleshed out. Conditions for both broth and plates have been discovered through the process of
plate counts and growth curves. Oxygen sensitivity and antibiotic sensitivity were also explored.
This background is extremely important to continue studying this emerging oral pathogen. This
knowledge allows for smooth laboratory research and can act as a foundation to study this
organism. For example, the data from the plate counts allowed for the completion of the
Hemagglutination/Hemolysis assay. This information was firmly used as the building blocks of
studying this oral bacterium. Without this essential process of collecting background information
on S. sputigena, there would be no direction to go in.
In addition to the established growth factors that were found in this study, virulence
factors were also looked at. The hypothesized virulence factors that were tested began with
Hemagglutination/Hemolysis assay and progressed to monospecies biofilm formation and
adhesion to oral epithelial cells. Hemagglutination/hemolysis showed a definite negative for that
virulence capability for S. sputigena. There is a possibility that it does form biofilms, both with
itself and with other oral pathogens, as the biofilm assay was lacking and needed significant
improvement. The adhesion assay, however, showed the capability of S. sputigena to bind to oral
epithelial cells which contributes to biofilm formation and colonization of the mouth. This
further results in the state of chronic inflammation, or periodontal disease. As more virulence
factors are discovered, this knowledge aids in moving forward while studying host/pathogen
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interaction, inflammation, colonization, and biofilm development during periodontal disease.
This can point further studies in the correct direction as we now know what to look for.
The last part of this project was studying the metabolism of cyclic-di-AMP by S.
sputigena. This secondary messenger can carry out many pathogenic and physiological functions
to both sustain homeostasis and cause disease. As the assay is still being developed, evidence for
S. sputigena having a diadenylate cyclase has been based, not only on the predicted protein
model by both SWISS-model and PHYRE, but on the literature as well. Due to bioinformatic
analysis it is probable that enzyme SELSP_1610, found in S. sputigena, acts as a diadenylate
cyclase. It appears to have DAC activity when compared to other structures from other
organisms like DacA in S. aureus (35,58). When studied in the enzymatic reaction run through
HPLC, several variables were changed including kinetics, such as reaction time, stoichiometry,
with protein concentration, cation of choice changed based off of the literary references and
predicted models, and change in buffer concentration (15,22). These meticulously chosen
variables help to point us in the correct direction for further assay development. More changes to
the assay are needed to continue building evidence that supports the bioinformatic analysis of
SELSP_1610.
Limitations and future directions
In terms of setbacks and future directions, all experiments for the growth factors need to
be replicated again with higher consistency now that a direction is established. This is especially
true for the plate counts that had high inconsistency and some contamination whenever
attempted. The biofilm assay needs to be refined with another reference protocol than the one
that was used in this study. A polymicrobial biofilm study should also be completed with S.
sputigena. The adhesion assay to TIGK cells needs to be pursued as well as a potential virulence
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factor that S. sputigena possesses. In addition to the growth and virulence factor study, the
remaining components of cyclic-di-AMP receptor proteins (SELSP_1770, SELSP_1836), and
degradation (SELSP_2051) need to be explored as well.
Each one of their potential activity, like the process for SELSP_1610, needs to be
analyzed through bioinformatics. Reverse phase chromatography can be used again to create an
assay with SELSP_2051 that contains possible PDE activity. Cyclic-di-AMP would be degraded
into pApA and this could be measured by running it through an HPLC column. If it does have a
PAS domain, heme can bind to this area and this can also be measured in an assay as well. An
assay can also be established to see if SELSP_1770 and SELSP_1836, possible TetR-family
transcriptional regulators, can bind to cyclic-di-AMP. As for SELSP_1610, future directions and
setbacks hinge on the assay discussed in this study. There are a few questions that might aid in
its development as well.
Diadenylate cyclases need to form a dimer in order to interact with ATP. Further research
would be needed to see if it naturally exists as a homodimer or it becomes one when it binds to
ATP (59). Another factor may be needed to assist in dimerization. Size exclusion
chromatography can be used to study this. A tyrosine “lock” was also mentioned in the literature
that slides the ATP into place (27,66). A known protein structure may aid in knowing if this
portion exists in the correct place. In addition to looking at structural changes in the enzyme,
cobalt was suggested to have the highest affinity in the reaction: even greater than the suggested
manganese (34). This would be another direction to go in as well. The truncated protein,
according to the literature, does not lose function due to the missing membrane domain so this is
not a possible reason as to why it is not working; however, the reason why it is crashing out of
solution may be a key to assay development (34). If the assay does not work, an ELISA is being
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developed as well in the lab to test for reduction in ATP presence using a known positive control
for diadenylate cyclase. This can further support the bioinformatics findings though, like the
initial assay, it needs to be refined. Coralyne, a molecule that binds to cyclic-di-AMP and
fluoresces, was the original proposed way of testing if SELSP_1610 is a diadenylate cyclase
(27,34). The assay had been replicated multiple times successfully in the literature; however,
coralyne is no longer commercially available. This led to more difficult and creative assay
development through reverse phase chromatography and ELISA to test this particular function.
Overall, periodontal disease is a detrimental disease with very little to no proper
treatment and preventative methods. This results in an inflammatory disease that can lead to life
threatening sequela. The treatment that does exist is invasive, dangerous, and is expensive and
requires better methods of care. This is contingent upon knowing and treating based upon
knowledge of the oral microbial community and the shift from healthy state to disease state.
Selenomonas sputigena is an emerging oral pathogen, and by seeking to study this organism,
better treatment options and tests can be provided for those suffering from periodontal disease.
References
1. Periodontal Disease | Oral Health Conditions | Division of Oral Health | CDC. (n.d.).
Retrieved from https://www.cdc.gov/oralhealth/conditions/periodontal-disease.html
2. (AAP), A. A. of P. (2019). Periodontal Disease Fact Sheet. American Academy of
Periodontology (AAP), Vol. 1–4. Retrieved from
https://www.perio.org/newsroom/periodontal-disease-fact-sheet
3. Agostoni, M., Logan-Jackson, A. R., Heinz, E. R., Severin, G. B., Bruger, E. L., Waters,
C. M., & Montgomery, B. L. (2018). Homeostasis of second messenger cyclic-di-AMP is
critical for cyanobacterial fitness and acclimation to abiotic stress. Frontiers in
Microbiology, 9(MAY), 1–13. https://doi.org/10.3389/fmicb.2018.01121
4. Amponsah, E., & Donkor, P. (2007). Life-threatening Oro-facial infections. Ghana
Medical Journal, 41(1), 33–36.

76

Keller
5. Aruni, A. W., Mishra, A., Dou, Y., Chioma, O., Hamilton, B. N., & Fletcher, H. M.
(2015). Filifactor alocis - a new emerging periodontal pathogen. Microbes and Infection,
17(7), 517–530. https://doi.org/10.1016/j.micinf.2015.03.011
6. Aruni, A. W., Roy, F., & Fletcher, H. M. (2011). Filifactor alocis has virulence attributes
that can enhance its persistence under oxidative stress conditions and mediate invasion of
epithelial cells by Porphyromonas gingivalis. Infection and Immunity, 79(10), 3872–
3886. https://doi.org/10.1128/IAI.05631-11
7. Aruni, W., Chioma, O., & Fletcher, H. M. (2014). Filifactor alocis: The newly discovered
kid on the block with special talents. Journal of Dental Research, 93(8), 725–732.
https://doi.org/10.1177/0022034514538283
8. Bai, Y., Yang, J., Zhou, X., Ding, X., Eisele, L. E., & Bai, G. (2012). Mycobacterium
tuberculosis Rv3586 (DacA) is a diadenylate cyclase that converts ATP or ADP into c-diamp. PLoS ONE, 7(4), 1–10. https://doi.org/10.1371/journal.pone.0035206
9. Bian, J., Liu, X., Cheng, Y. Q., & Li, C. (2013). Inactivation of cyclic di-GMP binding
protein TDE0214 affects the motility, biofilm formation, and virulence of Treponema
denticola. Journal of Bacteriology, 195(17), 3897–3905.
https://doi.org/10.1128/JB.00610-13
10. Bowman, L., Zeden, M. S., Schuster, C. F., Kaever, V., & Gründling, A. (2016). New
insights into the cyclic di-adenosine monophosphate (c-di-AMP) degradation pathway
and the requirement of the cyclic dinucleotide for acid stress resistance in Staphylococcus
aureu. Journal of Biological Chemistry, 291(53), 26970–26986.
https://doi.org/10.1074/jbc.M116.747709
11. Carrizales-Sepúlveda, E. F., Ordaz-Farías, A., Vera-Pineda, R., & Flores-Ramírez, R.
(2018). Periodontal Disease, Systemic Inflammation and the Risk of Cardiovascular
Disease. Heart Lung and Circulation, 27(11), 1327–1334.
https://doi.org/10.1016/j.hlc.2018.05.102
12. Carvajal, P., Gómez, M., Gomes, S., Costa, R., Toledo, A., Solanes, F., … Gamonal, J.
(2016). American adults : a cross sectional study. Journal of Applied Oral Science, 24(5).
13.

Chattopadhyay, I., Verma, M., & Panda, M. (2019). Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer. Technology in Cancer Research & Treatment, 18, 1–19.
https://doi.org/10.1177/1533033819867354

14. Chen, J., Wu, X., Zhu, D., Xu, M., Yu, Y., Yu, L., & Zhang, W. (2019). Microbiota in
Human Periodontal Abscess Revealed by 16S rDNA Sequencing. Frontiers in
Microbiology, 10(July), 1–12. https://doi.org/10.3389/fmicb.2019.01723
15. Childers, S. R. (1986). A high-performance liquid chromatography assay of brain
adenylate cyclase using [3H]ATP as substrate. Neurochemical Research, 11(2), 161–171.
https://doi.org/10.1007/BF00967965
16. Commichau, F. M., Gibhardt, J., Halbedel, S., Gundlach, J., & Stülke, J. (2018). A
Delicate Connection: c-di-AMP Affects Cell Integrity by Controlling Osmolyte
Transport. Trends in Microbiology, 26(3), 175–185.
https://doi.org/10.1016/j.tim.2017.09.003
17. Commichau, F. M., Heidemann, J. L., Ficner, R., & Stülke, J. (2019). Making and
breaking of an essential poison: The cyclases and phosphodiesterases that produce and
77

Keller
degrade the essential second messenger cyclic di-AMP in bacteria. Journal of
Bacteriology, 201(1), 1–14. https://doi.org/10.1128/JB.00462-18
18. Corrigan, R. M., & Gründling, A. (2013). Cyclic di-AMP: Another second messenger
enters the fray. Nature Reviews Microbiology, 11(8), 513–524.
https://doi.org/10.1038/nrmicro3069
19.

Daniel P. Miller, Qian Wang, Aaron Weinberg, and R. J. L. (2018). Transcriptome Analysis of Porphyromonas gingivalis and Acinetobacter baumannii in Polymicrobial Communities. Physiology & Behavior, (3),
139–148. https://doi.org/doi:10.1111/omi.12238

20. Devaux, L., Kaminski, P. A., Trieu-Cuot, P., & Firon, A. (2018). Cyclic di-AMP in host–
pathogen interactions. Current Opinion in Microbiology, 41, 21–28.
https://doi.org/10.1016/j.mib.2017.11.007
21. Diaz, P. I., Zilm, P. S., & Rogers, A. H. (2002). Fusobacterium nucleatum supports the
growth of Porphyromonas gingivalis in oxygenated and carbon-dioxide-depleted
environments. Microbiology, 148(2), 467–472. https://doi.org/10.1099/00221287-148-2467
22. Du, B., & Sun, J. H. (2015). Diadenylate cyclase evaluation of ssDacA (SSU98_1483) in
Streptococcus suis serotype 2. Genetics and Molecular Research, 14(2), 6917–6924.
https://doi.org/10.4238/2015.June.18.34
23. Elmanfi, S., Zhou, J., Sintim, H. O., Könönen, E., Gürsoy, M., & Gürsoy, U. K. (2019).
Regulation of gingival epithelial cytokine response by bacterial cyclic dinucleotides.
Journal of Oral Microbiology, 11(1). https://doi.org/10.1080/20002297.2018.1538927
24. Enersen, M., Nakano, K., & Amano, A. (2013). Porphyromonas gingivalis fimbriae.
Journal of Oral Microbiology, 5(2013), 1–10. https://doi.org/10.3402/jom.v5i0.20265
25. Fahmi, T., Port, G. C., & Cho, K. H. (2017). C-di-AMP: An essential molecule in the
signaling pathways that regulate the viability and virulence of gram-positive bacteria.
Genes, 8(8), 1–17. https://doi.org/10.3390/genes8080197
26. George Hajishengallis1,*, Richard P. Darveau2, and M. A. C. (2012). The Keystone
Pathogen Hypothesis George. 10(10), 4. https://doi.org/10.1038/nrmicro2873.The
27. Gibhardt, J., Heidemann, J. L., Bremenkamp, R., Rosenberg, J., Seifert, R., Kaever, V.,
… Commichau, F. M. (2020). An extracytoplasmic protein and a moonlighting enzyme
modulate synthesis of c-di-AMP in Listeria monocytogenes. Environmental
Microbiology, 22(7), 2771–2791. https://doi.org/10.1111/1462-2920.15008
28. Gürsoy, U. K., Gürsoy, M., Könönen, E., & Sintim, H. O. (2017). Cyclic dinucleotides in
oral bacteria and in oral biofilms. Frontiers in Cellular and Infection Microbiology,
7(JUN), 1–5. https://doi.org/10.3389/fcimb.2017.00273
29. Hajishengallis, G., & Lamont, R. J. (2016). The polymicrobial synergy and dysbiosis
model of periodontal disease pathogenesis. The Human Microbiota and Chronic Disease:
Dysbiosis as a Cause of Human Pathology, 227–242.
https://doi.org/10.1002/9781118982907.ch14
30. Hajishengallis2, R. J. L. and G. (2015). Polymicrobial synergy and dysbiosis in
inflammatory disease Richard. Physiology & Behavior, 176(5), 139–148.
https://doi.org/10.1016/j.physbeh.2017.03.040
78

Keller
31. Han, Y. W. (2016). Fusobacterium nucleatum: a commensal-turned pathogen NIH Public
Access. Curr Opin Microbiol, 141–147.
https://doi.org/10.1016/j.mib.2014.11.013.Fusobacterium
32. Han, Y. W., Redline, R. W., Li, M., Yin, L., Hill, G. B., & McCormick, T. S. (2004).
Fusobacterium nucleatum Induces Premature and Term Stillbirths in Pregnant Mice:
Implication of Oral Bacteria in Preterm Birth. Infection and Immunity, 72(4), 2272–2279.
https://doi.org/10.1128/IAI.72.4.2272-2279.2004
33. He, J., Yin, W., Galperin, M. Y., & Chou, S. H. (2020). Cyclic di-AMP, a second
messenger of primary importance: tertiary structures and binding mechanisms. Nucleic
Acids Research, 48(6), 2807–2829. https://doi.org/10.1093/nar/gkaa112
34.

Heidemann, J. L., Neumann, P., Dickmanns, A., & Ficner, R. (2019). Crystal structures of the c-di-AMP-synthesizing enzyme CdaA. Journal of Biological Chemistry, 294(27), 10463–10470.
https://doi.org/10.1074/jbc.RA119.009246

35. Heidemann, J. L., Neumann, P., Dickmanns, A., & Ficner, R. (n.d.). Supporting
Information Crystal structures of the c-di-AMP synthesizing enzyme CdaA. 1–7.
36. Hengge, R., Gründling, A., Jenal, U., Ryan, R., & Yildiz, F. (2016). Bacterial signal
transduction by cyclic di-GMP and other nucleotide second messengers. Journal of
Bacteriology, 198(1), 15–26. https://doi.org/10.1128/JB.00331-15
37. Ikeda, E., Shiba, T., Ikeda, Y., Suda, W., Nakasato, A., Takeuchi, Y., … Izumi, Y.
(2019). Japanese subgingival microbiota in health vs disease and their roles in predicted
functions associated with periodontitis. Odontology, (0123456789).
https://doi.org/10.1007/s10266-019-00452-4
38. Kapoor, A., Malhotra, R., Grover, V., & Grover, D. (2012). Systemic antibiotic therapy
in periodontics. Dental Research Journal, Vol. 9, p. 505. https://doi.org/10.4103/17353327.104866
39. Kim, H., Youn, S. J., Kim, S. O., Ko, J., Lee, J. O., & Choi, B. S. (2015). Structural
studies of potassium transport protein KtrA regulator of conductance of K+ (RCK) C
domain in complex with cyclic diadenosine monophosphate (c-di-AMP). Journal of
Biological Chemistry, 290(26), 16393–16402. https://doi.org/10.1074/jbc.M115.641340
40. Kim, S. M. (2019). Definition and management of odontogenic maxillary sinusitis.
Maxillofacial Plastic and Reconstructive Surgery, 41(1). https://doi.org/10.1186/s40902019-0196-2
41. Kingsley, V. V., & Hoeniger, J. F. M. (1973). Growth, structure, and classification of
Selenomonas. Bacteriological Reviews, 37(4), 479–521.
https://doi.org/10.1128/mmbr.37.4.479-521.1973
42. Kumar, P. S. (2017). From focal sepsis to periodontal medicine: a century of exploring
the role of the oral microbiome in systemic disease. Journal of Physiology, 595(2), 465–
476. https://doi.org/10.1113/JP272427
43. LI, X., KOLLTVEIT, K. M., TRONSTAD, L., & OLSEN, I. (2000). Systemic disease
caused by oral infection. Clinical Microbiologi reviews. Clin Med Res, 13(4), 547–558.
44.

Loesche, W. J. (1979). Clinical and Microbiological Aspects of Chemotherapeutic Agents Used According to the Specific Plaque Hypothesis. Journal of Dental Research, 58(12), 2404–2412.
https://doi.org/10.1177/00220345790580120905

79

Keller
45. Marsh, P. D. (2006). Dental plaque as a biofilm and a microbial community Implications for health and disease. BMC Oral Health, 6(SUPPL. 1), 1–7.
https://doi.org/10.1186/1472-6831-6-S1-S14
46. Masae Kuboniwa1, 2, John R. Houser3, Erik L. Hendrickson4, Qian Wang5, Samar A.
Alghamdi1, Akito Sakanaka1, Daniel P. Miller5, Justin A. Hutcherson5, Tiansong
Wang4, David A. C. Beck4, 6, Marvin Whiteley7, Atsuo Amano1, Huizhi Wang5,
Edward M. Marcotte3, and R. J. L. (2017). Metabolic crosstalk regulates Porphyromonas
gingivalis colonization and virulence during oral polymicrobial Infection. 2(11), 1493–
1499. https://doi.org/10.1038/s41564-017-0021-6.Metabolic
47. McCarthy, L. R., & Carlson, J. R. (1981). Selenomonas sputigena septicemia. Journal of
Clinical Microbiology, 14(6), 684–685. https://doi.org/10.1128/jcm.14.6.684-685.1981
48. Miller, D. P., Fitzsimonds, Z. R., & Lamont, R. J. (2019). Metabolic Signaling and
Spatial Interactions in the Oral Polymicrobial Community. Journal of Dental Research,
002203451986644. https://doi.org/10.1177/0022034519866440
49. Müller, M., Deimling, T., Hopfner, K. P., & Witte, G. (2015). Structural analysis of the
diadenylate cyclase reaction of DNA-integrity scanning protein A (DisA) and its
inhibition by 3′-dATP. Biochemical Journal, 469(3), 367–374.
https://doi.org/10.1042/BJ20150373
50. Nørskov-Lauritsen, N., Claesson, R., Jensen, A. B., Åberg, C. H., & Haubek, D. (2019).
Aggregatibacter Actinomycetemcomitans: Clinical significance of a pathobiont subjected
to ample changes in classification and nomenclature. Pathogens, 8(4).
https://doi.org/10.3390/pathogens8040243
51. Parashar, A., Parashar, S., Zingade, A., Gupta, S., & Sanikop, S. (2015). Interspecies
communication in oral biofilm: An ocean of information. Oral Science International,
12(2), 37–42. https://doi.org/10.1016/S1348-8643(15)00016-6
52.

Parashar, A., Parashar, S., Zingade, A., Gupta, S., & Sanikop, S. (2015). Interspecies communication in oral biofilm: An ocean of information. Oral Science International, 12(2), 37–42.
https://doi.org/10.1016/S1348-8643(15)00016-6

53. Paul I. Eke, PhD MPH*, Bruce A. Dye, DDS†, Liang Wei, MS‡, Gary D. Slade, BDSc
PhD∥, Gina O. Thornton-Evans, DDS§, Wenche S. Borgnakke, DDS PhD#, George W.
Taylor, D., & DrPH¶, Roy C. Page, DDS PhD**, James D. Beck, PhD∥, and Robert J.
Genco, D. P. (2019). Update on Prevalence of Periodontitis in Adults in the United
States: NHANES 2009 – 2012. Physiology & Behavior, 176(3), 139–148.
https://doi.org/10.1902/jop.2015.140520.Update
54. Prakasam, A., Elavarasu, Ss., & Natarajan, R. (2012). Antibiotics in the management of
aggressive periodontitis. Journal of Pharmacy and Bioallied Sciences, Vol. 4, p. 252.
https://doi.org/10.4103/0975-7406.100226
55. Raja, M., Ummer, F., & Dhivakar, C. P. (2014). Aggregatibacter
Actinomycetemcomitans - A Tooth Killer. Journal of Clinical and Diagnostic Research,
8(8), 13–16. https://doi.org/10.7860/JCDR/2014/9845.4766
56. Rath, C. B., Schirmeister, F., Figl, R., Seeberger, P. H., Schäffer, C., & Kolarich, D.
(2018). Flagellin glycoproteomics of the periodontitis associated pathogen selenomonas
sputigena reveals previously not described O-glycans and rhamnose fragment
80

Keller
rearrangement occurring on the glycopeptides. Molecular and Cellular Proteomics,
17(4), 721–736. https://doi.org/10.1074/mcp.RA117.000394
57. Richard J. Lamont, George N, Hajishengallis, Hyun (Michel) Koo, and H. F. J. (2019).
Oral Microbiology and Immunology Third Edition. In ASM Press.
https://doi.org/10.5260/chara.19.2.39
58. Rismondo, J., Gibhardt, J., Rosenberg, J., Kaever, V., Halbedel, S., & Commichau, F. M.
(2016). Phenotypes associated with the essential diadenylate cyclase CdaA and its
potential regulator CdaR in the human pathogen Listeria monocytogenes. Journal of
Bacteriology, 198(3), 416–426. https://doi.org/10.1128/JB.00845-15
59. Rosenberg, J., Dickmanns, A., Neumann, P., Gunka, K., Arens, J., Kaever, V., …
Commichau, F. M. (2015). Structural and biochemical analysis of the essential
diadenylate cyclase CdaA from Listeria monocytogenes. Journal of Biological
Chemistry, 290(10), 6596–6606. https://doi.org/10.1074/jbc.M114.630418
60. Rosier, B. T., De Jager, M., Zaura, E., & Krom, B. P. (2014). Historical and
contemporary hypotheses on the development of oral diseases: Are we there yet?
Frontiers in Cellular and Infection Microbiology, 4(JUL), 1–11.
https://doi.org/10.3389/fcimb.2014.00092
61. Ruano, P., Delgado, L. L., Picco, S., Villegas, L., Tonelli, F., Merlo, M., … Masuelli, M.
(2016). We are IntechOpen , the world ’ s leading publisher of Open Access books Built
by scientists , for scientists TOP 1 %. Intech, (tourism), 13. Retrieved from
https://www.intechopen.com/books/advanced-biometric-technologies/liveness-detectionin-biometrics
62. Ryan, R. P. (2013). Cyclic di-GMP signalling and the regulation of bacterial virulence.
Microbiology (United Kingdom), 159(PART7), 1286–1297.
https://doi.org/10.1099/mic.0.068189-0
63.

Ryan, R. P., Fouhy, Y., Lucey, J. F., & Dow, J. M. (2006). Cyclic di-GMP signaling in bacteria: Recent advances and new puzzles. Journal of Bacteriology, 188(24), 8327–8334. https://doi.org/10.1128/JB.01079-06

64. Ryan, R. P., Fouhy, Y., Lucey, J. F., & Dow, J. M. (2006). Cyclic di-GMP signaling in
bacteria: Recent advances and new puzzles. Journal of Bacteriology, 188(24), 8327–
8334. https://doi.org/10.1128/JB.01079-06
65. Steegborn, C. (2014). Structure, mechanism, and regulation of soluble adenylyl cyclases similarities and differences to transmembrane adenylyl cyclases. Biochimica et
Biophysica Acta - Molecular Basis of Disease, 1842(12), 2535–2547.
https://doi.org/10.1016/j.bbadis.2014.08.012
66. Sureka, K., Choi, P. H., Precit, M., Delince, M., Pensinger, D. A., Huynh, T. A. N., …
Woodward, J. J. (2014). The cyclic dinucleotide c-di-AMP is an allosteric regulator of
metabolic enzyme function. Cell, 158(6), 1389–1401.
https://doi.org/10.1016/j.cell.2014.07.046
67. Suzuki, N., Yoneda, M., & Hirofuji, T. (2013). Mixed red-complex bacterial infection in
periodontitis. International Journal of Dentistry, 2013.
https://doi.org/10.1155/2013/587279
81

Keller
68. Tonetti, M. S., Jepsen, S., Jin, L., & Otomo-Corgel, J. (2017). Impact of the global
burden of periodontal diseases on health, nutrition and wellbeing of mankind: A call for
global action. Journal of Clinical Periodontology, 44(5), 456–462.
https://doi.org/10.1111/jcpe.12732
69. Tosi, T., Hoshiga, F., Millership, C., Singh, R., Eldrid, C., Patin, D., … Gründling, A.
(2019). Inhibition of the Staphylococcus aureus c-di-AMP cyclase DacA by direct
interaction with the phosphoglucosamine mutase GlmM. PLoS Pathogens, 15(1), 1–28.
https://doi.org/10.1371/journal.ppat.1007537
70. Wang, Q., Wright, C. J., Dingming, H., Uriarte, S. M., & Lamont, R. J. (2013). Oral
Community Interactions of Filifactor alocis In Vitro. PLoS ONE, 8(10), 1–9.
https://doi.org/10.1371/journal.pone.0076271
71. Wang, Y. (2017). ePortfolios: A new peer assessment technology in educational context.
Prevalence of Periodontal Disease, Its Association with Systemic Diseases and
Prevention, 1(2), 360–363. https://doi.org/10.1109/ISIP.2008.139
72. Witte, C. E., Whiteley, A. T., Burke, T. P., Sauer, J. D., Portnoy, D. A., & Woodward, J.
J. (2013). Cyclic di-AMP is critical for Listeria monocytogenes growth, cell wall
homeostasis, and establishment of infection. MBio, 4(3), 1–10.
https://doi.org/10.1128/mBio.00282-13
73. Witte, G., Hartung, S., Büttner, K., & Hopfner, K. P. (2008). Structural Biochemistry of a
Bacterial Checkpoint Protein Reveals Diadenylate Cyclase Activity Regulated by DNA
Recombination Intermediates. Molecular Cell, 30(2), 167–178.
https://doi.org/10.1016/j.molcel.2008.02.020
74. Xian Penga, b, Yang Zhangc, Guangchun Baic, Xuedong Zhoub, and H. W. (2017).
Cyclic di-AMP mediates biofilm formation. Physiology & Behavior, 176(3), 139–148.
https://doi.org/10.1111/mmi.13277.Cyclic
75. Xu, L., Venkataramani, P., Ding, Y., Liu, Y., Deng, Y., Yong, G. L., … Liang, Z. X.
(2016). A cyclic di-GMP-binding adaptor protein interacts with histidine kinase to
regulate two-component signaling. Journal of Biological Chemistry, 291(31), 16112–
16123. https://doi.org/10.1074/jbc.M116.730887
76. Periodontal Disease in Adults (Age 20 to 64) | National Institute of Dental and
Craniofacial Research. (2018). Retrieved from https://www.nidcr.nih.gov/research/datastatistics/periodontal-disease/adults
77. Nagpal, D., Prakash, S., Bhat, K. G., & Singh, G. (2016). Detection and comparison of
Selenomonas sputigena in subgingival biofilms in chronic and aggressive periodontitis
patients. Journal of Indian Society of Periodontology, Vol. 20, pp. 286–291.
https://doi.org/10.4103/0972-124X.181247
78. Kolenbrander, P. E., Andersen, R. N., & Moore, L. V. H. (1989). Coaggregation of
Fusobacterium nucleatum, Selenomonas flueggei, Selenomonas infelix, Selenomonas
noxia, and Selenomonas sputigena with strains from 11 genera of oral bacteria. Infection
and Immunity, Vol. 57, pp. 3194–3203. https://doi.org/10.1128/iai.57.10.3194-3203.1989
82

Keller

79. Kumada, H., Watanabe, K., Nakamu, A., Haishima, Y., Kondo, S., Hisatsune, K., &
Umemoto, T. (1997). Chemical and biological properties of lipopolysaccharide from
Selenomonas sputigena ATCC 33150. Oral Microbiology and Immunology, 12(3), 162–
167. https://doi.org/10.1111/j.1399-302X.1997.tb00373.x

83

